Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Novel perspectives on the transcytotic route in osteoclasts.

Hirvonen MJ, Fagerlund K, Lakkakorpi P, Väänänen HK, Mulari MT.

Bonekey Rep. 2013 Mar 13;2:306. doi: 10.1038/bonekey.2013.40. eCollection 2013.

2.

Novel interaction of Rab13 and Rab8 with endospanins.

Hirvonen MJ, Büki KG, Sun Y, Mulari MT, Härkönen PL, Väänänen KH.

FEBS Open Bio. 2013 Jan 22;3:83-8. doi: 10.1016/j.fob.2013.01.004. Print 2013.

3.

Rab13 is upregulated during osteoclast differentiation and associates with small vesicles revealing polarized distribution in resorbing cells.

Hirvonen MJ, Mulari MT, Büki KG, Vihko P, Härkönen PL, Väänänen HK.

J Histochem Cytochem. 2012 Jul;60(7):537-49. doi: 10.1369/0022155412448069. Epub 2012 May 4.

4.

Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.

Morko J, Kiviranta R, Mulari MT, Ivaska KK, Väänänen HK, Vuorio E, Laitala-Leinonen T.

Bone. 2009 Apr;44(4):717-28. doi: 10.1016/j.bone.2008.11.019. Epub 2008 Dec 11.

PMID:
19118660
5.

Can elevated serum TRACP-5b levels predict stress fractures? A cohort study.

Ruohola JP, Mulari M, Haataja RI, Väänänen HK, Pihlajamäki HK.

Scand J Surg. 2009;98(4):239-43.

PMID:
20218422
6.

Recombinant VSV G proteins reveal a novel raft-dependent endocytic pathway in resorbing osteoclasts.

Mulari MT, Nars M, Laitala-Leinonen T, Kaisto T, Metsikkö K, Sun Y, Väänänen HK.

Exp Cell Res. 2008 May 1;314(8):1641-51. doi: 10.1016/j.yexcr.2008.02.011. Epub 2008 Mar 4.

PMID:
18387607
7.

Death of osteocytes turns off the inhibition of osteoclasts and triggers local bone resorption.

Gu G, Mulari M, Peng Z, Hentunen TA, Väänänen HK.

Biochem Biophys Res Commun. 2005 Oct 7;335(4):1095-101.

PMID:
16111656
8.

Osteoblast-like cells complete osteoclastic bone resorption and form new mineralized bone matrix in vitro.

Mulari MT, Qu Q, Härkönen PL, Väänänen HK.

Calcif Tissue Int. 2004 Sep;75(3):253-61.

PMID:
15148559
9.

Intracellular membrane trafficking in bone resorbing osteoclasts.

Mulari M, Vääräniemi J, Väänänen HK.

Microsc Res Tech. 2003 Aug 15;61(6):496-503. Review.

PMID:
12879417
10.

The architecture of microtubular network and Golgi orientation in osteoclasts--major differences between avian and mammalian species.

Mulari MT, Patrikainen L, Kaisto T, Metsikkö K, Salo JJ, Väänänen HK.

Exp Cell Res. 2003 May 1;285(2):221-35.

PMID:
12706117
11.

Osteoclast ruffled border has distinct subdomains for secretion and degraded matrix uptake.

Mulari MT, Zhao H, Lakkakorpi PT, Väänänen HK.

Traffic. 2003 Feb;4(2):113-25.

12.

Cellular distribution and contribution of cyclooxygenase COX-2 to diabetogenesis in NOD mouse.

Luo C, Kallajoki M, Gross R, Mulari M, Teros T, Ylinen L, Mäkinen M, Laine J, Simell O.

Cell Tissue Res. 2002 Nov;310(2):169-75. Epub 2002 Aug 27.

PMID:
12397372
13.

Alendronate disturbs vesicular trafficking in osteoclasts.

Alakangas A, Selander K, Mulari M, Halleen J, Lehenkari P, Mönkkönen J, Salo J, Väänänen K.

Calcif Tissue Int. 2002 Jan;70(1):40-7. Epub 2001 Dec 21.

PMID:
11907706
14.

Regulation of acrosome formation in mice expressing green fluorescent protein as a marker.

Ventelä S, Mulari M, Okabe M, Tanaka H, Nishimune Y, Toppari J, Parvinen M.

Tissue Cell. 2000 Dec;32(6):501-7.

PMID:
11197232
15.

The cell biology of osteoclast function.

Väänänen HK, Zhao H, Mulari M, Halleen JM.

J Cell Sci. 2000 Feb;113 ( Pt 3):377-81. Review.

16.

Endocytic pathway from the basal plasma membrane to the ruffled border membrane in bone-resorbing osteoclasts.

Palokangas H, Mulari M, Väänänen HK.

J Cell Sci. 1997 Aug;110 ( Pt 15):1767-80.

17.

Removal of osteoclast bone resorption products by transcytosis.

Salo J, Lehenkari P, Mulari M, Metsikkö K, Väänänen HK.

Science. 1997 Apr 11;276(5310):270-3.

Supplemental Content

Loading ...
Support Center